Cutaneous squamous cell carcinoma. Italian Guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines
Authors:
- Ketty PerisKPKetty Peris
- on behalf of the Italian Group of Dermato-Oncology (GIDO) of SIDeMaSTOSon behalf of the Italian Group of Dermato-Oncology (GIDO) of SIDeMaST
- Mauro AlaibacMauro Alaibac
- Giuseppe ArgenzianoGAGiuseppe Argenziano
- Alessandro Di StefaniASAlessandro Di Stefani
- Maria C. FargnoliMFMaria C. Fargnoli
- Pasquale FrascionePFPasquale Frascione
- Giulio GualdiGGGiulio Gualdi
- Caterina LongoCLCaterina Longo
- Elvira MoscarellaEMElvira Moscarella
- Luigi NaldiLNLuigi Naldi
- Giovanni PellacaniGPGiovanni Pellacani
- 1 December 2018
- journal article
- research article
- Published by Edizioni Minerva Medica in Italian Journal of Dermatology and Venereology
- Vol. 153 (6) , 747-762
Abstract
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, accounting for 20% of all cutaneous malignancies, and has an increasing incidence in the elderly as well as in the younger population. Although most cSCC is treated with simple therapeutic procedures, advanced cSCC can lead a significant risk for morbidity, negative impact on quality of life, and death. Proper management includes distinguishing between high-risk and low-risk lesions and determining treatment accordingly. A collaboration of multidisciplinary Italian experts has given birth to these recommendations on cSCC diagnosis and management, based on a critical review of the literature, existing European (EADO-EDF-EORTC) guidelines and the expert's experience. Topics covered include diagnostic path and histopathologic assessment, tumor staging, surgical and nonsurgical procedures, follow-up and management of localized and advanced disease.Keywords
This publication has 107 references indexed in Scilit:
- Tumor Recurrence 5 Years after Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell CarcinomaJournal of Investigative Dermatology, 2013
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinomaJournal of Clinical Investigation, 2012
- Randomized controlled trial of acitretin versus placebo in patients at high‐risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)Cancer, 2011
- Skin cancer in solid organ transplant recipients: Advances in therapy and managementJournal of the American Academy of Dermatology, 2011
- Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approachDermatologic Therapy, 2010
- Srcasm Inhibits Fyn-Induced Cutaneous Carcinogenesis with Modulation of Notch1 and p53Cancer Research, 2009
- Intralesional methotrexate treatment for keratoacanthoma tumors: A retrospective study and review of the literatureJournal of the American Academy of Dermatology, 2007
- Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantationJournal of the American Academy of Dermatology, 1995
- Adjuvant radiotherapy after excision of cutaneous squamous cell carcinomaJournal of the American Academy of Dermatology, 1994